Novavax(NVAX) - 2025 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 12, 2026 NOVAVAX, INC. (Exact name of registrant as specified in charter) (State or Other Jurisdiction of Incorporation) Delaware 0-26770 22-2816046 (Commission File Number) (I.R.S. Employer Identification No.) 21 Firstfield Road Gaithersburg, Maryland 20878 (Address of Principal Execut ...